Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...